Gene · 8742
Papers2,943
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 2,943
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Free Bilirubin Induces Neuro-Inflammation in an Induced Pluripotent Stem Cell-Derived Cortical Organoid Model of Crigler-Najjar Syndrome. | Cells | 2023 | 37759499 | PubTator, text mining | PubMed |
| Roles of interferon regulatory factor 4 in the AKI-CKD transition, glomerular diseases and kidney allograft rejection. | Ren Fail | 2023 | 37755331 | PubTator, text mining | PubMed |
| Bispecific T-Cell Engagers and Chimeric Antigen Receptor T-Cell Therapies in Glioblastoma: An Update. | Curr Oncol | 2023 | 37754534 | PubTator, text mining | PubMed |
| Genome-wide landscape of runs of homozygosity and differentiation across Egyptian goat breeds. | BMC Genomics | 2023 | 37752425 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing reveals the heterogeneity and intercellular communication of hepatic stellate cells and macrophages during liver fibrosis. | MedComm (2020) | 2023 | 37724132 | PubTator, text mining | PubMed |
| Survival and biomarkers for cachexia in non-small cell lung cancer receiving immune checkpoint inhibitors. | Cancer Med | 2023 | 37712645 | PubTator, text mining | PubMed |
Efficacy, safety, and biomarker analysis of nivolumab in combination with abemaciclib plus endocrine therapy in patients with HR-positive HER2-negative metastatic breast cancer: a phase II study (WJOG11418B NEWFLAME trial). | J Immunother Cancer | 2023 | 37709297 | PubTator, text mining | PubMed |
| Systematic transcriptional analysis of human cell lines for gene expression landscape and tumor representation. | Nat Commun | 2023 | 37669926 | PubTator, text mining | PubMed |
| The usefulness of tumor necrosis factor-like weak inducer of apoptosis in patients with acute ST-elevation myocardial infarction. | Eur Rev Med Pharmacol Sci | 2023 | 37667941 | PubTator, text mining | PubMed |
| Review on Metal-Based Theranostic Nanoparticles for Cancer Therapy and Imaging. | Technol Cancer Res Treat | 2023 | 37642945 | PubTator, text mining | PubMed |
| The Role and Applications of Exosomes in Gynecological Cancer: A Review. | Cell Transplant | 2023 | 37632354 | PubTator, text mining | PubMed |
| Gut Microbiota Interventions to Retain Residual Kidney Function. | Toxins (Basel) | 2023 | 37624256 | PubTator, text mining | PubMed |
| RNA modification: mechanisms and therapeutic targets. | Mol Biomed | 2023 | 37612540 | PubTator, text mining | PubMed |
| M6A-mediated-upregulation of lncRNA BLACAT3 promotes bladder cancer angiogenesis and hematogenous metastasis through YBX3 nuclear shuttling and enhancing NCF2 transcription. | Oncogene | 2023 | 37612524 | PubTator, text mining | PubMed |
| Using deep long-read RNAseq in Alzheimer's disease brain to assess medical relevance of RNA isoform diversity. | bioRxiv | 2023 | 37609156 | PubTator, text mining | PubMed |
| Peripheral inflammatory biomarkers are associated with cognitive function and dementia: Framingham Heart Study Offspring cohort. | Aging Cell | 2023 | 37584418 | PubTator, text mining | PubMed |
| Proteome-Wide Mendelian Randomization Analysis Identified Potential Drug Targets for Atrial Fibrillation. | J Am Heart Assoc | 2023 | 37581400 | PubTator, text mining | PubMed |
| Single-cell analysis reveals cellular reprogramming in advanced colon cancer following FOLFOX-bevacizumab treatment. | Front Oncol | 2023 | 37576892 | PubTator, text mining | PubMed |
| Impaired skeletal muscle health in Parkinsonian syndromes: clinical implications, mechanisms and potential treatments. | J Cachexia Sarcopenia Muscle | 2023 | 37574254 | PubTator, text mining | PubMed |
| Drug Development from Natural Products Based on the Pathogenic Mechanism of Asthma. | Int J Mol Sci | 2023 | 37569846 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8742/papers?page=20